Medical News

RSS

Proposed health research agency for UK

According to the Academy of Medical Sciences, a new body to regulate all health research in the UK should be established. The authorities suggest that the current regulatory system was dysfunctional and thus hampering medical advances and they blame red tape for the decline in the UK’s share of clinical research. The report suggests creating a Health Research Agency that would make approving projects quicker and cheaper. According to Health Secretary for England, Andrew Lansley, the government would consider how the recommendations could be implemented.

11 Jan 2011

Vitamin drinks contain too much sugar: CHOICE review

According to consumer group CHOICE the available vitamin-enhanced water products, produced by such companies as Nutrient Water, Smart Water and Vitamin Water, often contain high levels of sugar and in some cases were branded in a way that suggested they contained ingredients that were non-existent.

11 Jan 2011

SciClone initiates phase 2b study of SCV-O7 for oral mucositis

SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) -- a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.

11 Jan 2011

Stigma remains over Major Depressive Disorder

Despite there being 39.1 million people suffering from major depressive disorder (MDD) across the seven major markets, only one third of patients will seek help from a physician, finds latest research from independent analyst Datamonitor.

11 Jan 2011

FairWarning achieves two KLAS Konfidence checkmarks

FairWarning, Inc., a leading supplier of solutions which monitor and protect patient privacy in Electronic Health Records, has achieved two KLAS Konfidence checkmarks, indicating KLAS has surveyed between 20 and 29 of FairWarning®'s customers.

11 Jan 2011

Nicotine may act as treatment for some symptoms of schizophrenia

Smoking is a common problem for patients with schizophrenia. The increased tendency of patients diagnosed with this disorder is to not only smoke, but to do so more heavily than the general public. This raises the possibility that nicotine may be acting as a treatment for some symptoms of schizophrenia.

11 Jan 2011

Race, ethnicity and geography influence colon cancer screening

New research from UC Davis Cancer Center has found that whether a person gets screened for colon cancer often depends on where they live in addition to their race or ethnicity.

11 Jan 2011

TearLab's Osmolarity test made available at point-of-care

TearLab Corporation and COLA, a private, non-profit clinical laboratory education, consultation and accreditation organization, announced today that they have partnered to help make the TearLab™ Osmolarity System available in the U.S. at the point-of-care.

11 Jan 2011

Geisinger implements NextGate's patient indexing software

NextGate, a leader in the IT indexing field, today announced that Geisinger Health System, widely recognized for its advanced electronic health record (EHR) and execution of innovative care models, is implementing NextGate's patient indexing software. The software will enhance the coordination of patient data across the health system and enable care providers to access patients' most up-to-date clinical information regardless of location.

11 Jan 2011

VIPdesk becomes wholly-owned subsidiary of International SOS

International SOS, the world's leading integrated medical and security assistance and concierge services company, and VIPdesk, the North American provider of industry-leading concierge services, customer care and loyalty programs, announced today the joining of forces to bring together the first truly integrated, global concierge and customer care service delivery platform.

11 Jan 2011

Novelda announces CMOS Impulse Radar Transceiver designed for ETSI and FCC compliance

Novelda AS announced today a CMOS Impulse Radar Transceiver designed for ETSI and FCC compliance within the 6.0GHz - 8.5GHz UWB-mask.

11 Jan 2011

First Edition: January 11, 2011

Today's headlines include reports about how a recent high court ruling may offer clues as to how the Supreme Court will view a key aspect of the health overhaul law.

11 Jan 2011

Zogenix, Desitin receive MAA approval for SUMAVEL DosePro in Germany and the UK

Aradigm Corporation today announced that Zogenix, Inc. and Desitin Pharmaceuticals GmbH were granted approval of the Marketing Authorization Application for SUMAVEL® DosePro™ (sumatriptan injection) needle-free delivery system for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache by the Federal Institute for Drugs and Medical Devices of Germany (BrArM) and the Medicines and Healthcare products Regulatory Agency of the United Kingdom (MHRA).

11 Jan 2011

EffRx moves to Switzerland

Former EffRx, Inc., Jupiter, FL, USA is now EffRx Pharmaceuticals SA, Biopôle, Route de la Corniche 4, Epalinges/Lausanne, Switzerland. The move took place on September 18, 2010 through a share exchange agreement.

11 Jan 2011

ALLOZYNE completes AZ01 Phase IA clinical trial in relapsing remitting multiple sclerosis

ALLOZYNE, Inc. announced today, the completion of its first Phase IA clinical trial in healthy individuals for AZ01, a PEGylated form of human interferon beta-1b which is being developed for the treatment of relapsing remitting multiple sclerosis. The objectives of the Phase IA trial were to assess safety and tolerability profile in addition to defining its pharmacological properties.

11 Jan 2011

Cyclacel opens enrollment of sapacitabine Phase 3 trial for AML

Cyclacel Pharmaceuticals, Inc., today announced that it has opened enrollment of the SEAMLESS pivotal Phase 3 trial for the Company's sapacitabine oral capsules as a front-line treatment of elderly patients aged 70 years or older with newly diagnosed acute myeloid leukemia (AML) who are not candidates for intensive induction chemotherapy.

11 Jan 2011

DynaVox Mayer-Johnson announces Boardmaker Player for Windows

DynaVox Mayer-Johnson, the leading provider of speech generating devices and symbol-adapted special education software used to assist individuals in overcoming speech, language and learning challenges, today announced Boardmaker Player for Windows.

11 Jan 2011

Group health insurance policies help attract high calibre employees

Group health insurance policies are an excellent means of attracting high calibre employees to your business. That's according to advisers from Health Insurance Solutions.

11 Jan 2011

California's DWC releases new medical bill regulations for public comment

New California electronic medical billing regulations and revised paper medical billing requirements were released January 6th for public comment by California's Division of Workers Compensation (DWC). The regulations, part of the Division's 12-point plan to help control medical costs in California's workers' compensation system, will be signed into law in approximately 60 days.

11 Jan 2011

HITRUST designates PwC as a Common Security Framework Assessor

PwC US announced today that the Health Information Trust Alliance (HITRUST) has designated the firm a Common Security Framework (CSF) Assessor, qualified to evaluate and certify security standards of CSF-related services.

11 Jan 2011